Sukhshant Atti

Sukhshant Atti practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Sukhshant Atti's NPI, 1306272141, was assigned on September 25, 2013. Sukhshant Atti holds Alabama license 40826.

Sukhshant Atti's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Sukhshant Atti's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Sukhshant Atti is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Sukhshant Atti practices. Vendor and product names are available with a free account.

Emergency medicine is Sukhshant Atti's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Sukhshant Atti is licensed in Alabama.

CMS data shows 198 Medicare services from Sukhshant Atti across 4 procedure codes in 2024, for 205 Medicare patients. Medicare paid $19,098 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 205 Medicare patients who saw Sukhshant Atti in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sukhshant Atti's median patient age at 44, with 57% women.

In 2024, Sukhshant Atti wrote 178 Medicare Part D claims for 114 patients. 91% of them were for generic drugs. CMS names the drug for 59 of them, across 3 drugs with 11 or more claims each, at $403 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

Sukhshant Atti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Sukhshant Atti from 2 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $18.